Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC)

Price 99.80p on 20-12-2024 at 17:30:00
Change 0.20p 0.2%
Buy 100.40p
Sell 100.00p
Buy / Sell SYNC Shares
Last Trade: Sell 49,723.00 at 99.80p
Day's Volume: 1,725,640
Last Close: 99.80p
Open: 100.20p
ISIN: GG00B8P59C08
Day's Range 99.80p - 100.40p
52wk Range: 99.20p - 131.60p
Market Capitalisation: £626m
VWAP: 99.93814p
Shares in Issue: 628m

Recent Trades History Syncona (SYNC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 49,723 99.80p SI Trade
16:48:11 - 20-Dec-24
Sell* 1,156,890 99.80p Uncrossing Trade
16:35:21 - 20-Dec-24
Sell* 3,542 100.20p SI Trade
16:29:55 - 20-Dec-24
Sell* 747 100.00p Automatic Execution
16:29:00 - 20-Dec-24
Sell* 746 100.00p Automatic Execution
16:27:17 - 20-Dec-24
Sell* 2,903 100.20p Automatic Execution
16:26:31 - 20-Dec-24
Sell* 317 100.20p Automatic Execution
16:26:22 - 20-Dec-24
Sell* 320 100.20p Automatic Execution
16:26:22 - 20-Dec-24
Sell* 19 100.20p Automatic Execution
16:26:22 - 20-Dec-24
Sell* 5,277 100.20p Automatic Execution
16:26:22 - 20-Dec-24

Share Price History for Syncona

Time period:
to
Date Open High Low Close Volume

Share News for Syncona

Syncona hails positive trial data for new Beacon Therapeutics drug

6th Dec 2024 14:55

(Alliance News) - Syncona Ltd on Friday reported promising trial results for the drug laru-zova, the lead asset of Syncona subsidiary Beacon Therapeutics Holdings Ltd. Read More

Syncona net assets values down; announces new portfolio firm Slingshot

14th Nov 2024 12:28

(Alliance News) - Syncona Ltd on Thursday said it launched a new portfolio company as it reported a fall in net asset value, citing a weaker US dollar. Read More

Syncona's Autolus wins FDA approval for aggressive leukaemia therapy

11th Nov 2024 10:28

(Alliance News) - Syncona Ltd announced on Monday that the US Food & Drug Administration has granted marketing approval to one of its portfolio companies for a new product. Read More

UK earnings, trading statements calendar - next 7 days

7th Nov 2024 16:23

Read More

Syncona celebrates investee's positive trial data on Gaucher disease

23rd Oct 2024 09:37

(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's disease. Read More

FTSE 100 Latest
Value8,084.61
Change-20.71

Login to your account

Forgot Password?

Not Registered